MRC1 and inflammatory bowel disease: We have previously shown that anti-TNF induces highly immunosuppressive CD14+ CD163+ CD206+ macrophages which promote epithelial wound healing.4,5 In a cohort of IBD patients, the induction of such macrophages correlated with endoscopic response to infliximab.